Literature DB >> 152790

Tumor neutralization, immunotherapy, and chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro: II. Comparison of cells cultured with and without tumor to noncultured immune cells.

M A Cheever, P D Greenberg, A Fefer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 152790

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  13 in total

1.  Enhancement of immunity against RSV-induced sarcomas by generation of hapten-reactive helper T lymphocytes.

Authors:  P M Comoglio; M Prat; S Bretti
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

2.  The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice.

Authors:  H F Dullens; W Vuist; M Van der Maas; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 3.  Specific adoptive immunotherapy: experimental basis and future potential.

Authors:  P D Greenberg; M A Cheever; A Fefer
Journal:  Surv Immunol Res       Date:  1982

4.  Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor.

Authors:  T J Eberlein; M Rosenstein; P Spiess; R Wesley; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

5.  Antigenic variation in cancer metastasis: immune escape versus immune control.

Authors:  V Schirrmacher; M Fogel; E Russmann; K Bosslet; P Altevogt; L Beck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

6.  Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

Authors:  M A Cheever; P D Greenberg; A Fefer; S Gillis
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

7.  Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo.

Authors:  D H Lynch; R E Miller
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

8.  Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.

Authors:  E Fernandez-Cruz; B A Woda; J D Feldman
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

9.  Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2.

Authors:  T J Eberlein; M Rosenstein; S A Rosenberg
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

10.  Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.

Authors:  P D Greenberg; M A Cheever; A Fefer
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.